David Smith
Family Medicine · Grand Ledge, MINPI 1275623662
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,645 of the $5,760 with a category attached, or 80.6%. 33 manufacturers reported payments, led by Novo Nordisk at 27.0% of the total. Reporting peaked in 2022 at $2,306 and has fallen 98.6% since, to $33 in 2025. Among family medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 384 payments — averaging $15.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Bayer$1K
- AbbVie$624
- AstraZeneca$332
- Lilly USA, LLC$315
- Amgen$269
- plus $1K from 27 others
What the payments were for
- Consulting fees$1,08219%
- Food & beverage$4,64581%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 178 | $1,558 |
| Bayer | 7 | $1,168 |
| AbbVie | 63 | $624 |
| AstraZeneca | 8 | $332 |
| Lilly USA, LLC | 26 | $315 |
| Amgen | 18 | $269 |
| Pfizer | 14 | $267 |
| Boehringer Ingelheim | 8 | $137 |
| Johnson & Johnson | 4 | $113 |
| GSK | 7 | $99 |
| Boston Scientific | 1 | $91 |
| Merck | 5 | $82 |
| Amarin Pharma, Inc. | 5 | $76 |
| Sanofi-aventis U.S. LLC | 5 | $76 |
| Novartis | 5 | $66 |
| Astellas Pharma US Inc | 4 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $52 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Dexcom, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $31 |
| GRT US Holding, Inc. | 2 | $29 |
| Abbott | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
| Halozyme Inc | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Gilead | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,760 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Grand Ledge
- Timothy IzzoGrand Ledge$124K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.